How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

446 results for

Cutaneous Candidiasis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. AAWC Pressure Ulcer Guidelines

as indicated by ulcer severity or chronicity, and if treated, document treatment and its duration. (Bryant et al., 1983; Lewis et al 1988; Milne et al, 2009) e.g. fistulae, abscesses, osteomyelitis, bacteremia, cellulitis, cancer, heterotopic bone formation 5. For individuals with a PU it is important to perform differential diagnoses (e.g. skin tear, Herpes lesions, incontinence-associated dermatitis, candidiasis, arterial insufficiency ulcer) to improve accuracy of pressure ulcer diagnosis (Konishi et al (...) ) E. SURGICAL INTERVENTIONS (Brown et al., 2007;Isik et al. 1997; Wong & Ip 2006; Yamamoto et al 1997) 1. Direct closure (Whitney et al 2006) seldom helps unless pressure source is eliminated and PU is small (Brown et al., 2007) 2. Flaps: Myocutaneous free, fasciocutaneous, cutaneous (Ichioka et al 2007; Lemaire et al 2008; Wong & Ip 2006; Rennert et al 2009; Yamamoto et al 1997) 3. Skin grafts (Whitney et al., 2006) though they exhibit ?poor take? over exposed bone (Brown et al., 2007) 4

2011 Association for the Advancement of Wound Care

122. Quantitation of ergosterol content and gene expression profile of ERG11 gene in fluconazole-resistant Candida albicans (PubMed)

immunocompromised patients, namely recurrent oral, vaginal, and cutaneous candidiasis, during 2015-16. Antifungal susceptibility testing of fluconazole against clinical Candida species was performed according to Clinical and Laboratory Standards Institute guidelines. Ergosterol content and gene expression profiling of sterol 14α-demethylase (ERG11) gene in fluconazole-susceptible and -resistant C. albicans were investigated.The specimens consisted of C. albicans (46.67%), Candida krusei (41.67%), and Candida

Full Text available with Trip Pro

2017 Current Medical Mycology

123. In vitro antifungal activity of essential oils extracted from plants against fluconazole-susceptible and -resistant Candida albicans (PubMed)

fluconazole-resistant and 20 susceptible C. albicans isolates obtained from oral, vaginal, and cutaneous tissues of patients with candidiasis were evaluated. The efficacy and minimum inhibitory concentrations (MICs) of Zataria multiflora, Geranium herbarum,Lavendula officinalis,Cuminum, cyminum,Allium heamanthoides, and Artemisia sieberi essential oils against C. albicans were determined on the basis of a reference method for broth microdilution susceptibility testing of yeasts as suggested by Clinical (...) essential oils against both azoles-resistant and azoles-susceptible isolates were similar. Given the documented resistance of different Candida species to synthetic and chemical antifungals, these essential oils are effective replacement treatments for cutaneous and mucosal Candida infections, especially in resistant or recurrent cases.

Full Text available with Trip Pro

2017 Current Medical Mycology

124. Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease (PubMed)

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease Heterozygous STAT1 gain-of-function (GOF) mutations are associated with chronic mucocutaneous candidiasis and a broad spectrum of infectious, inflammatory, and vascular manifestations. We describe therapeutic failures with the Janus Kinase (JAK) inhibitor ruxolitinib in 2 STAT1 GOF patients with severe invasive or cutaneous fungal infections.

Full Text available with Trip Pro

2017 Open forum infectious diseases

126. Dermatologic manifestations of endocrine disorders (PubMed)

contributes to a thickening of skin and soft tissue, which manifests as coarsening and enlargement of facial and acral structures. Stimulation of the thyrotropin receptor in hyperthyroidism results in mesenchymal tissue proliferation and consequent pretibial myxedema; other associated cutaneous features include onycholysis, and hyperhidrosis. Individuals with hypothyroidism exhibit cold, dry skin and brittle hair as well as a jaundice-like appearance due to carotene excess. The cutaneous features (...) features including chronic mucocutaneous candidiasis, vitiligo, and alopecia areata. This paper highlights the underlying pathophysiology, dermatologic manifestations, and treatment of the aforementioned endocrine disorders.

Full Text available with Trip Pro

2017 Translational pediatrics

128. Monitoring of Nonsteroidal Immunosuppressive Drugs in Patients With Lung Disease and Lung Transplant Recipients

antagonists in? iximab and adali- mumab. 75 Other infections that have been reported in patients treated with etanercept in postmarketing studies include endemic fungi, atypical mycobacte- ria, candidiasis, aspergillosis, cytomegalovirus, herpes zoster, Pneumocystis , and Listeria monocytogenes . There has been substantial controversy regarding the use of TNF antagonists in patients with cardio- myopathy, resulting in a black box warning from the FDA for in? iximab use in patients with New York Heart

2012 American College of Chest Physicians

129. Long-Term Management of the Successful Adult Liver Transplant

population 41 (Table 10). The cumulative incidence of de novo cancer after LT increases from 3% to 5% at 1 to 3 years to 11% to 20% at 10 years after LT. 42,43 Cutaneous malignancies are the most common form of malignancy in recipients of solid organ transplants, but cigarette smokers are at increased risk of developing lung cancer and oropha- ryngeal cancer, and the rate of colon cancer is increased in patients undergoing transplantation for PSC because of the comorbid risk from in?ammatory bowel (...) recurrences. Recommendations 41. All LT recipients should see a dermatologist af- ter transplantation to assess cutaneous lesions, with at least an annual evaluation by a derma- tologist 5 years or more after transplantation (grade 1, level A). 42. Patients with PSC and in?ammatory bowel dis- ease or other established risk factors for colo- rectal cancer should undergo an annual screening colonoscopy with biopsies. Colec- tomy, including continence-preserving pouch operations, should be considered when

2012 American Association for the Study of Liver Diseases

130. Treatment of Fungal Infections in Adult Pulmonary, Critical Care, and Sleep Medicine: An Official ATS Statement

A. Stevens, on behalf of the American Thoracic Society Fungal Working Group THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY (ATS) WAS APPROVED BY THE ATS BOARD OF DIRECTORS, MAY 2010 CONTENTS Introduction Methods Antifungal Agents: General Considerations Polyenes Triazoles Echinocandins Treatment of Fungal Infections Histoplasmosis Sporotrichosis Blastomycosis Coccidioidomycosis Paracoccidioidomycosis Cryptococcosis Aspergillosis Candidiasis Pneumocystis Pneumonia Treatment of Other Fungi (...) mycoses, including histoplasmosis, sporotrichosis, blastomycosis, and coccidioidomycosis; fungal infections of special concern for immune-compromised and critically ill patients, including crypto- coccosis, aspergillosis, candidiasis, and Pneumocystis pneumonia; andrareandemergingfungalinfections. Keywords: fungal pneumonia; amphotericin; triazole antifungal; echinocandin The incidence, diagnosis, and clinical severity of pulmonary fungal infections have dramatically increased in recent years

2011 American Thoracic Society

131. Use of cost effective and rapid molecular tools for identification of Candida species, opportunistic pathogens (PubMed)

Use of cost effective and rapid molecular tools for identification of Candida species, opportunistic pathogens Candidiasis is a widespread fungal infection caused by different Candida species. Rapid identification of Candida species in clinical laboratory is becoming increasingly important since the identification and discrimination of ethological agents for early treatment. We aimed at molecular identification of commonly Candida species isolated from clinical samples by using both PCR-RFLP (...) assay and amplification of hwp1 gene.Clinical samples comprising of vaginal specimens ,cutaneous, sputum, bronchoalveolar lavage(BAL,( and blood cultures were recovered from suspected patients. Candida isolates were initially identified phenotypically and confirmed by molecular approaches based on restriction fragment length polymorphism (PCR-RFLP (with MspI restriction enzyme. Amplification of hwp1 gene was performed for discrimination of C. albicans from C. dubliniensis and C.africana.The most

Full Text available with Trip Pro

2016 Current Medical Mycology

132. Skin Immunity to Candida albicans (PubMed)

Skin Immunity to Candida albicans Candida albicans is a dimorphic commensal fungus that colonizes healthy human skin, mucosa, and the reproductive tract. C. albicans is also a predominantly opportunistic fungal pathogen, leading to disease manifestations such as disseminated candidiasis and chronic mucocutaneous candidiasis (CMC). The differing host susceptibilities for the sites of C. albicans infection have revealed tissue compartmentalization with tailoring of immune responses based (...) on the site of infection. Furthermore, extensive studies of host genetics in rare cases of CMC have identified conserved genetic pathways involved in immune recognition and the response to the extracellular pathogen. We focus here on human and mouse skin as a site of C. albicans infection, and we review established and newly discovered insights into the cellular pathways that promote cutaneous antifungal immunity.Copyright © 2016 Elsevier Ltd. All rights reserved.

Full Text available with Trip Pro

2016 Trends in immunology

133. Dual T cell– and B cell–intrinsic deficiency in humans with biallelic RLTPR mutations (PubMed)

Dual T cell– and B cell–intrinsic deficiency in humans with biallelic RLTPR mutations Combined immunodeficiency (CID) refers to inborn errors of human T cells that also affect B cells because of the T cell deficit or an additional B cell-intrinsic deficit. In this study, we report six patients from three unrelated families with biallelic loss-of-function mutations in RLTPR, the mouse orthologue of which is essential for CD28 signaling. The patients have cutaneous and pulmonary allergy (...) , as well as a variety of bacterial and fungal infectious diseases, including invasive tuberculosis and mucocutaneous candidiasis. Proportions of circulating regulatory T cells and memory CD4+ T cells are reduced. Their CD4+ T cells do not respond to CD28 stimulation. Their CD4+ T cells exhibit a "Th2" cell bias ex vivo and when cultured in vitro, contrasting with the paucity of "Th1," "Th17," and T follicular helper cells. The patients also display few memory B cells and poor antibody responses. This B

Full Text available with Trip Pro

2016 The Journal of experimental medicine

134. Injection Laryngoplasty Using Autologous Fat Enriched With Adipose Derived Regenerative Stem Cells (ADRC)

Exclusion Criteria: Patients affected by kidney insufficiency, presenting a seric creatinine higher than 2.5 mg/dl. Medical history of allergy to proteins, or other allergies that could lead to a safety problem if the patient joins the present clinical trial. Acute infectious disease at the moment of enrollment. Chronic infectious disease affecting directly or indirectly the anatomical area that is going to be operated (it includes tuberculosis, brucellosis, chronic candidiasis and cutaneous chronic

2016 Clinical Trials

135. Filaggrin gene mutations and the distribution of filaggrin in oral mucosa of patients with oral lichen planus and healthy controls. (PubMed)

may be altered in these lesions.To investigate whether patients with OLP/OLL have (i) altered distribution of filaggrin in the oral mucosa; (ii) a higher incidence of mutations in the filaggrin gene (FLG); (iii) active dermatoses, apart from cutaneous LP, than healthy controls; and (iv) patients with OLP/OLL and a defect in the FLG have more widespread oral lesions and report more symptoms than OLP/OLL patients without a concomitant defect in the FLG.Forty-nine Caucasian patients (42 women and 7 (...) men, mean age 61.0 ± 10.3 years), with symptomatic OLP, OLL or stomatitis, and 29 matched healthy controls underwent a clinical oral and dermatological examination, oral mucosal biopsy and filaggrin genotyping (testing for R2447X, R501X, 2282del4). Smear tests for Candida spp. were performed in all patients to exclude oral candidiasis. Immunohistochemistry were performed using poly- and monoclonal filaggrin antibodies.The immunoreactivity for filaggrin was significantly more intense in the oral

2016 Journal of the European Academy of Dermatology and Venereology

136. Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study. (PubMed)

for infections with significantly higher risk in the glucocorticoid-exposed population ranged from 2.01 (95% CI 1.83-2.19; p < 0.001) for cutaneous cellulitis to 5.84 (95% CI 5.61-6.08; p < 0.001) for lower respiratory tract infection (LRTI). There was no difference in the risk of scabies, dermatophytosis and varicella. The relative increase in risk was stable over the durations of exposure, except for LRTI and local candidiasis, for which it was much higher during the first weeks of exposure. The risks (...) or varicella, which may have led to limited statistical power.The relative risk of LRTI and local candidiasis is very high during the first weeks of glucocorticoid exposure. Further studies are needed to assess whether low albumin level is a risk factor for infection by itself (e.g., by being associated with a higher free glucocorticoid fraction) or whether it reflects other underlying causes of general debilitation.

Full Text available with Trip Pro

2016 PLoS medicine

137. Thrush

areas of the body and is generally caused by Candida albicans; includes chronic mucocutaneous candidiasis, cutaneous candidiasis, oral candidiasis (thrush), and monilial vaginitis. Concepts Disease or Syndrome ( T047 ) MSH ICD9 112.9, 112 ICD10 , SnomedCT 187005005 , 187024008 , 187478002 , 154403005 , 370520002 , 78048006 English Candidiases , Candidiasis , Moniliases , Moniliasis , CANDIDIASIS , MONILIASIS , Candidiasis, unspecified , [X]Candidiasis, unspecified , candidiasis , candidiasis (...) Thrush Thrush Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Thrush Thrush Aka: Thrush , Oral Candidiasis , Candida Albicans

2018 FP Notebook

138. Abituzumab in SSc-ILD

in volume (millilitre [mL]) [ Time Frame: Week 52 or prematurely discontinued from the trial, whichever occur first ] Secondary Outcome Measures : Change in dyspnea from baseline as measured by the Mahler Transition Dyspnea Index (TDI) [ Time Frame: at Week 52 ] Absolute change from baseline in St. George Respiratory Questionnaire (SGRQ) total score [ Time Frame: at Week 52 ] Absolute change from baseline in Modified Rodnan skin score (mRSS) at Week 52 in subjects with diffuse cutaneous skin involvement (...) Completion of oral anti-infectives within 2 weeks of Screening Use of oral anti-infectives during Screening Period Vaginal candidiasis onychomycosis chronically suppressed oral herpes simplex virus Prophylaxis for Pneumocystis jiroveci pneumonia History of/positive Human immunodeficiency virus, hepatitis C antibody and/or polymerase chain reaction or Hepatitis B surface antigen and/or hepatitis B core antibody (total and/or Immunoglobulin M) antibody at screening. History of/current diagnosis of active

2016 Clinical Trials

139. Prospective Evaluation of a New Approach to Perform an Esophageal Myotomy: the Transesophageal Submucosa Approach

of myotomy, innovative and less invasive, called POEM (PerOral Endoscopic Myotomy). This technique does not require any cutaneous incision. Mini-invasive surgery is more and more associated to endoscopy. The practice was initiated by the accession of natural orifice transluminal endoscopic surgery (NOTES). In this context, the introduction of the POEM technique seems to be an original approach and a natural evolution to a new generation of surgical endoscopy. Condition or disease Intervention/treatment (...) (EGD) Contraindication to general anesthesia BMI above 40 kg/m² Infectious esophagitis (e.g. candidiasis) Psychiatric context unsuitable with an experimental protocol Allergy to beta-lactam Contraindication to endoscopy (esophageal stenosis, suspicion of digestive perforation, state of shock, severe anemia, cardiorespiratory failure or severe metabolic disorders) Contraindication to monitored pneumoperitoneum (cardiorespiratory failure or severe metabolic disorders) Inability to give an informed

2016 Clinical Trials

140. Skin conditions in a South African tuberculosis hospital: Prevalence, description, and possible associations. (PubMed)

-resistant TB. The most prevalent dermatosis was xerosis (n = 83, 79%), followed by oral candidiasis (n = 33, 31%) and scars (n = 33, 31%), finger clubbing (n = 31, 29%), leukonychia (n = 29, 28%), striae (n = 25, 24%), and facial hyperpigmentation (n = 22, 21%). Anemia was detected in 90 (86%) patients, and 75 (71%) were classified as being underweight. Three patients were diagnosed with cutaneous TB.Patients hospitalized with TB have on average four different dermatoses, but xerosis remains the leading (...) dermatological finding, irrespective of HIV status or TB drug sensitivity. Anemia and malnutrition are associated with numerous skin conditions found in this population. The prevalence of cutaneous TB among patients hospitalized with TB remains low, despite the high rate of TB and HIV co-infection.© 2016 The International Society of Dermatology.

2016 International Journal of Dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>